Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia
21 sept. 2024 04h15 HE
|
Teva Pharmaceutical Industries Ltd
As a leader in neuroscience, Teva is committed to researching new treatment innovations that may help address unmet needs in treating schizophrenia, including TEV-‘749Currently, there is no...
New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)
21 sept. 2024 04h10 HE
|
Teva Pharmaceutical Industries Ltd
As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific and clinical advances that support optimal treatment options and...
ACADIA HEALTHCARE COMPANY, INC. ANNOUNCEMENT: If You Have Suffered Losses in Acadia Healthcare Company, Inc. (NASDAQ: ACHC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
20 sept. 2024 21h17 HE
|
The Rosen Law Firm PA
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Acadia...
ROSEN, A LEADING LAW FIRM, Encourages WEBTOON Entertainment Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBTN
20 sept. 2024 21h07 HE
|
The Rosen Law Firm PA
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of WEBTOON Entertainment Inc. (NASDAQ: WBTN) pursuant and/or...
Bragar Eagel & Squire, P.C. Is Investigating LPL Financial, Bumble, Cardlytics, and European Wax and Encourages Investors to Contact the Firm
20 sept. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against LPL Financial Holdings...
Bragar Eagel & Squire, P.C. Is Investigating Dyne, Napco, and Franklin and Encourages Investors to Contact the Firm
20 sept. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Dyne Therapeutics, Inc....
Bragar Eagel & Squire, P.C. Is Investigating Aviat and Flux and Encourages Investors to Contact the Firm
20 sept. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Aviat Networks, Inc....
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Metagenomi and Encourages Investors to Contact the Firm
20 sept. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against MaxLinear, Inc. (NASDAQ:...
American Airlines ALERT: Bragar Eagel & Squire, P.C. is Investigating American Airlines Group Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
20 sept. 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against American Airlines Group...
AGEN Class Action Notice: Robbins LLP Reminds Agenus Inc. Stockholders of Pending AGEN Class Action Lawsuit
20 sept. 2024 20h05 HE
|
Robbins LLP
Robbins LLP is Investigating Allegations that Agenus Inc. (AGEN) Misled Investors Regarding the Viability of its Drug Candidates